Global Injectable Nanomedicines Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1330

In 2018, the global Injectable Nanomedicines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Injectable Nanomedicines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Injectable Nanomedicines development in United States, Europe and China.

The key players covered in this study
Pfizer
Johnson & Johnson
Merck
Roche
Lupin
Teva Pharmaceutical
Bausch Health
Celgene
Amgen
Pacira Pharmaceuticals

Market segment by Type, the product can be split into
Liposomes
Micelles
Nanocrystals
Others

Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Injectable Nanomedicines status, future forecast, growth opportunity, key market and key players.
To present the Injectable Nanomedicines development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Injectable Nanomedicines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Injectable Nanomedicines Market Size Growth Rate by Type (2014-2025)
1.4.2 Liposomes
1.4.3 Micelles
1.4.4 Nanocrystals
1.4.5 Others
1.5 Market by Application
1.5.1 Global Injectable Nanomedicines Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Injectable Nanomedicines Market Size
2.2 Injectable Nanomedicines Growth Trends by Regions
2.2.1 Injectable Nanomedicines Market Size by Regions (2014-2025)
2.2.2 Injectable Nanomedicines Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Injectable Nanomedicines Market Size by Manufacturers
3.1.1 Global Injectable Nanomedicines Revenue by Manufacturers (2014-2019)
3.1.2 Global Injectable Nanomedicines Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Injectable Nanomedicines Market Concentration Ratio (CR5 and HHI)
3.2 Injectable Nanomedicines Key Players Head office and Area Served
3.3 Key Players Injectable Nanomedicines Product/Solution/Service
3.4 Date of Enter into Injectable Nanomedicines Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Injectable Nanomedicines Market Size by Type (2014-2019)
4.2 Global Injectable Nanomedicines Market Size by Application (2014-2019)

5 United States
5.1 United States Injectable Nanomedicines Market Size (2014-2019)
5.2 Injectable Nanomedicines Key Players in United States
5.3 United States Injectable Nanomedicines Market Size by Type
5.4 United States Injectable Nanomedicines Market Size by Application

6 Europe
6.1 Europe Injectable Nanomedicines Market Size (2014-2019)
6.2 Injectable Nanomedicines Key Players in Europe
6.3 Europe Injectable Nanomedicines Market Size by Type
6.4 Europe Injectable Nanomedicines Market Size by Application

7 China
7.1 China Injectable Nanomedicines Market Size (2014-2019)
7.2 Injectable Nanomedicines Key Players in China
7.3 China Injectable Nanomedicines Market Size by Type
7.4 China Injectable Nanomedicines Market Size by Application

8 Japan
8.1 Japan Injectable Nanomedicines Market Size (2014-2019)
8.2 Injectable Nanomedicines Key Players in Japan
8.3 Japan Injectable Nanomedicines Market Size by Type
8.4 Japan Injectable Nanomedicines Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Injectable Nanomedicines Market Size (2014-2019)
9.2 Injectable Nanomedicines Key Players in Southeast Asia
9.3 Southeast Asia Injectable Nanomedicines Market Size by Type
9.4 Southeast Asia Injectable Nanomedicines Market Size by Application

10 India
10.1 India Injectable Nanomedicines Market Size (2014-2019)
10.2 Injectable Nanomedicines Key Players in India
10.3 India Injectable Nanomedicines Market Size by Type
10.4 India Injectable Nanomedicines Market Size by Application

11 Central & South America
11.1 Central & South America Injectable Nanomedicines Market Size (2014-2019)
11.2 Injectable Nanomedicines Key Players in Central & South America
11.3 Central & South America Injectable Nanomedicines Market Size by Type
11.4 Central & South America Injectable Nanomedicines Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Injectable Nanomedicines Introduction
12.1.4 Pfizer Revenue in Injectable Nanomedicines Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Company Details
12.2.2 Company Description and Business Overview
12.2.3 Injectable Nanomedicines Introduction
12.2.4 Johnson & Johnson Revenue in Injectable Nanomedicines Business (2014-2019)
12.2.5 Johnson & Johnson Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Injectable Nanomedicines Introduction
12.3.4 Merck Revenue in Injectable Nanomedicines Business (2014-2019)
12.3.5 Merck Recent Development
12.4 Roche
12.4.1 Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Injectable Nanomedicines Introduction
12.4.4 Roche Revenue in Injectable Nanomedicines Business (2014-2019)
12.4.5 Roche Recent Development
12.5 Lupin
12.5.1 Lupin Company Details
12.5.2 Company Description and Business Overview
12.5.3 Injectable Nanomedicines Introduction
12.5.4 Lupin Revenue in Injectable Nanomedicines Business (2014-2019)
12.5.5 Lupin Recent Development
12.6 Teva Pharmaceutical
12.6.1 Teva Pharmaceutical Company Details
12.6.2 Company Description and Business Overview
12.6.3 Injectable Nanomedicines Introduction
12.6.4 Teva Pharmaceutical Revenue in Injectable Nanomedicines Business (2014-2019)
12.6.5 Teva Pharmaceutical Recent Development
12.7 Bausch Health
12.7.1 Bausch Health Company Details
12.7.2 Company Description and Business Overview
12.7.3 Injectable Nanomedicines Introduction
12.7.4 Bausch Health Revenue in Injectable Nanomedicines Business (2014-2019)
12.7.5 Bausch Health Recent Development
12.8 Celgene
12.8.1 Celgene Company Details
12.8.2 Company Description and Business Overview
12.8.3 Injectable Nanomedicines Introduction
12.8.4 Celgene Revenue in Injectable Nanomedicines Business (2014-2019)
12.8.5 Celgene Recent Development
12.9 Amgen
12.9.1 Amgen Company Details
12.9.2 Company Description and Business Overview
12.9.3 Injectable Nanomedicines Introduction
12.9.4 Amgen Revenue in Injectable Nanomedicines Business (2014-2019)
12.9.5 Amgen Recent Development
12.10 Pacira Pharmaceuticals
12.10.1 Pacira Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Injectable Nanomedicines Introduction
12.10.4 Pacira Pharmaceuticals Revenue in Injectable Nanomedicines Business (2014-2019)
12.10.5 Pacira Pharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details